Biogen forecasts upbeat annual profit, eyes 2028 launch of key drugs
Go back to Biogen forecasts upbeat annual profit, eyes 2028 launch of key drugs| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 222.25 +6.21 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.04 | 52 Week High | $333.65 | |||
| Open | $218.20 | 52 Week Low | $223.02 | |||
| Day High | $223.00 | P/E | 28.46 | |||
| Day Low | $216.97 | EPS | $7.81 | |||
| Volume | 381,460 | |||||
